4BASEBIO PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,410 GBX | -1.74% |
|
+21.55% | +107.35% |
| 04-10 | 4basebio to supply synthetic DNA for mRNA vaccine program | AN |
| 04-10 | 4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 229M | - | - | - | - | - | |
| 42.12B | ||||||
| 42.05B | ||||||
| 29.18B | ||||||
| 26.02B | ||||||
| 18.9B | - |
- Stock Market
- Equities
- 4BB Stock
- Charts 4basebio PLC
- Sector Chart